Artesunate/amodiaquine

DRUG2 trials

Sponsors

Universiteit Antwerpen, Ukah Chukwuemeka Marcel

Conditions

MalariaMalaria Pregnancy and Childbirth

Phase 3

Impact of Artemisinin-based Combination Therapy and Quinine on Treatment Failure and Resistance in Uncomplicated Malaria

CompletedNCT01374581

Universiteit AntwerpenMalaria

Start: 2012-05-31End: 2014-06-30Updated: 2014-10-22

Unknown Phase

ARTEMETHER-LUMEFANTRINE VERSUS ARTESUNATE- AMODIAQUINE IN PREGNANT WOMEN

Active, not recruitingPACTR201310000484185

Ukah Chukwuemeka MarcelMalaria Pregnancy and Childbirth

Start: 2013-01-17Target: 150Updated: 2026-01-27

Related Papers

Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial.

2016-11-1115 citations

Uncomplicated Clinical Malaria Features, the Efficacy of Artesunate-Amodiaquine and Their Relation with Multiplicity of Infection in the Democratic Republic of Congo

PLoS ONE2016-06-0922 citations

A randomized trial of artesunate‐amodiaquine versus artemether‐lumefantrine for the treatment of acute uncomplicated malaria in pregnancy

International Journal of Gynecology & Obstetrics2015-07-0310 citations

Impact of retreatment with an artemisinin-based combination on malaria incidence and its potential selection of resistant strains: study protocol for a randomized controlled clinical trial.

2013-09-2311 citations